292 related articles for article (PubMed ID: 36077694)
1. Homologous Recombination Deficiency Scar: Mutations and Beyond-Implications for Precision Oncology.
van der Wiel AMA; Schuitmaker L; Cong Y; Theys J; Van Hoeck A; Vens C; Lambin P; Yaromina A; Dubois LJ
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077694
[TBL] [Abstract][Full Text] [Related]
2. Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types.
Takamatsu S; Brown JB; Yamaguchi K; Hamanishi J; Yamanoi K; Takaya H; Kaneyasu T; Mori S; Mandai M; Matsumura N
JCO Precis Oncol; 2021 Aug; 5():. PubMed ID: 34423229
[TBL] [Abstract][Full Text] [Related]
3. Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types.
Takamatsu S; Brown JB; Yamaguchi K; Hamanishi J; Yamanoi K; Takaya H; Kaneyasu T; Mori S; Mandai M; Matsumura N
JCO Precis Oncol; 2022 May; 6():e2200085. PubMed ID: 35613413
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for Homologous Recombination Deficiency in Cancer.
Hoppe MM; Sundar R; Tan DSP; Jeyasekharan AD
J Natl Cancer Inst; 2018 Jul; 110(7):704-713. PubMed ID: 29788099
[TBL] [Abstract][Full Text] [Related]
5. Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes.
Timms KM; Abkevich V; Hughes E; Neff C; Reid J; Morris B; Kalva S; Potter J; Tran TV; Chen J; Iliev D; Sangale Z; Tikishvili E; Perry M; Zharkikh A; Gutin A; Lanchbury JS
Breast Cancer Res; 2014 Dec; 16(6):475. PubMed ID: 25475740
[TBL] [Abstract][Full Text] [Related]
6. Detection and therapeutic implications of homologous recombination repair deficiency in pancreatic cancer: a narrative review.
Tan H; Hosein PJ
J Gastrointest Oncol; 2023 Oct; 14(5):2249-2259. PubMed ID: 37969835
[TBL] [Abstract][Full Text] [Related]
7. RAD51 as a functional biomarker for homologous recombination deficiency in cancer: a promising addition to the HRD toolbox?
van Wijk LM; Nilas AB; Vrieling H; Vreeswijk MPG
Expert Rev Mol Diagn; 2022 Feb; 22(2):185-199. PubMed ID: 34913794
[TBL] [Abstract][Full Text] [Related]
8. Homologous Recombination Abnormalities Associated With
Albitar M; Zhang H; Pecora A; Waintraub S; Graham D; Hellmann M; McNamara D; Charifa A; De Dios I; Ma W; Goy A
Breast Cancer (Auckl); 2023; 17():11782234231198979. PubMed ID: 37789896
[TBL] [Abstract][Full Text] [Related]
9. Functional
Meijer TG; Verkaik NS; Sieuwerts AM; van Riet J; Naipal KAT; van Deurzen CHM; den Bakker MA; Sleddens HFBM; Dubbink HJ; den Toom TD; Dinjens WNM; Lips E; Nederlof PM; Smid M; van de Werken HJG; Kanaar R; Martens JWM; Jager A; van Gent DC
Clin Cancer Res; 2018 Dec; 24(24):6277-6287. PubMed ID: 30139880
[TBL] [Abstract][Full Text] [Related]
10. The Homologous Recombination Deficiency Scar in Advanced Cancer: Agnostic Targeting of Damaged DNA Repair.
Pacheco-Barcia V; Muñoz A; Castro E; Ballesteros AI; Marquina G; González-Díaz I; Colomer R; Romero-Laorden N
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740616
[No Abstract] [Full Text] [Related]
11. Characterization, Detection, and Treatment Approaches for Homologous Recombination Deficiency in Cancer.
O'Kane GM; Connor AA; Gallinger S
Trends Mol Med; 2017 Dec; 23(12):1121-1137. PubMed ID: 29133135
[TBL] [Abstract][Full Text] [Related]
12. Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort.
Leibowitz BD; Dougherty BV; Bell JSK; Kapilivsky J; Michuda J; Sedgewick AJ; Munson WA; Chandra TA; Dry JR; Beaubier N; Igartua C; Taxter T
BMC Cancer; 2022 May; 22(1):587. PubMed ID: 35643464
[TBL] [Abstract][Full Text] [Related]
13. Genomic Determinants of Homologous Recombination Deficiency across Human Cancers.
Qing T; Wang X; Jun T; Ding L; Pusztai L; Huang KL
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572800
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Review and Meta-Analysis on the Prognostic Value of BRCA Mutations, Homologous Recombination Gene Mutations, and Homologous Recombination Deficiencies in Cancer.
Shao C; Chang MS; Lam FC; Marley AR; Tang H; Song Y; Miller C; Brown M; Wan I; Han J; Adeboyeje G
J Oncol; 2022; 2022():5830475. PubMed ID: 35909902
[TBL] [Abstract][Full Text] [Related]
15. [Homologous recombination repair deficiency as a predictive biomarker : Basic mechanisms and detection methods].
Pfarr N; Merkelbach-Bruse S
Pathologe; 2021 Jul; 42(4):391-398. PubMed ID: 34152463
[TBL] [Abstract][Full Text] [Related]
16. Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis.
Casolino R; Paiella S; Azzolina D; Beer PA; Corbo V; Lorenzoni G; Gregori D; Golan T; Braconi C; Froeling FEM; Milella M; Scarpa A; Pea A; Malleo G; Salvia R; Bassi C; Chang DK; Biankin AV
J Clin Oncol; 2021 Aug; 39(23):2617-2631. PubMed ID: 34197182
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers for Homologous Recombination Deficiency in Cancer.
Wagener-Ryczek S; Merkelbach-Bruse S; Siemanowski J
J Pers Med; 2021 Jun; 11(7):. PubMed ID: 34203281
[TBL] [Abstract][Full Text] [Related]
18. Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD).
Rempel E; Kluck K; Beck S; Ourailidis I; Kazdal D; Neumann O; Volckmar AL; Kirchner M; Goldschmid H; Pfarr N; Weichert W; Hübschmann D; Fröhling S; Sutter C; Schaaf CP; Schirmacher P; Endris V; Stenzinger A; Budczies J
NPJ Precis Oncol; 2022 Jun; 6(1):36. PubMed ID: 35681079
[TBL] [Abstract][Full Text] [Related]
19. Patient Assessment and Therapy Planning Based on Homologous Recombination Repair Deficiency.
Li W; Gao L; Yi X; Shi S; Huang J; Shi L; Zhou X; Wu L; Ying J
Genomics Proteomics Bioinformatics; 2023 Oct; 21(5):962-975. PubMed ID: 36791952
[TBL] [Abstract][Full Text] [Related]
20. Ovarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors.
Miller RE; Elyashiv O; El-Shakankery KH; Ledermann JA
Onco Targets Ther; 2022; 15():1105-1117. PubMed ID: 36217436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
